• Latest Posts

European Pharma closes 2016 by launching new Biotech Startups

FDA and EMA review the First Therapy for a Deadly Skin Cancer

Cellectis gets paid for a first Milestone, Investors are pleased

Israeli Cancer Startup catches Investment from 3 major Big Pharma

How Good was 2015 for the French Universal CAR-T Biotech?


Also Using PD-L1 Cancer Treatments to Attack Alzheimer’s Disease

Novartis Attacks Amgen. Amgen wants to Ruin Roche – The New Biosimilar War!

Finally, Pfizer acquires Botox-maker Allergan for €150Bn to move to tax-friendly Ireland!

Get to Know the Top 50 Women in the UK’s Biotech Scene

Why has the Universal CAR-T Treatment For Leukemia Hooked TWO Big Pharmas at Once?